New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00035854

Locations


United States, California
	Research Center
	Los Angeles, California, United States, 90095
	Research Center
	Los Angeles, California, United States, 90027
	Research Center
	Long Beach, California, United States, 90806

United States, Connecticut
	Research Center
	Hartford, Connecticut, United States, 06106

United States, District of Columbia
	Research Center
	Washington, District of Columbia, United States, 20010

United States, Florida
	Research Center
	Gainesville, Florida, United States, 32610
	Research Center
	Gainesville, Florida, United States, 32610

United States, Georgia
	Research Center
	Atlanta, Georgia, United States, 30342

United States, Illinois
	Research Center
	Park Ridge, Illinois, United States, 60068
	Research Center
	Chicago, Illinois, United States, 60614

United States, Kentucky
	Research Center
	Louisville, Kentucky, United States, 40202

United States, Maryland
	Research Center
	Baltimore, Maryland, United States, 21287

United States, Massachusetts
	Research Center
	Boston, Massachusetts, United States, 02111

United States, Michigan
	Research Center
	Detroit, Michigan, United States, 48201

United States, New Jersey
	Research Center
	Camden, New Jersey, United States, 08103

United States, New York
	Research Center
	New York, New York, United States, 10029
	Research Center
	New York, New York, United States, 10032
	Research Center
	New York, New York, United States, 10021

United States, Ohio
	Research Center
	Cleveland, Ohio, United States, 44195

United States, Pennsylvania
	Research Center
	Philadelphia, Pennsylvania, United States, 19104
	Research Center
	Danville, Pennsylvania, United States, 17822

United States, Texas
	Research Center
	Austin, Texas, United States, 78701

Sponsors and Collaborators

Pfizer